Skip to main content

Table 3 Future health of women with PAS

From: Pregnancy-associated stroke –a systematic review of subsequent pregnancies and maternal health

Author

Women in cohort (n)

PAS women n (%)

Types of events included in follow-up

Cardiovascular events reported for PAS

Mortality

Underlying condition

Duration of follow-up

Alebeek et al. (2018) [28]

213

20 (9)

Stroke or other arterial event, eg. MI or cardiovascular procedure

3 recurrent ischaemic strokes

nr

2 SLE, 2 APS, 7 hypertension, 1 DM, 6 smoking

mean 14.8, SD 10.0 y

Appenzeller et al. (2005) [24]

18

6 (33)

CVT or other thrombotic event

none

none

none

mean 46, range 11–145 mo

Breteau et al. (2003) [21]

42

3 (7)

CVT recurrence, DVT, PE, any other health problem leading to hospitalisation

no recurrent CVT

none

nr

median 36, range 12–60 mo

Ertresvg et al. (2007)

41

2 (5)

Any new diseases

none

none

1 APS + pre-eclampsia, 1 smoking + family histrory of stroke + FV Leiden heterozygous

5 y

Gastrich et al. (2012) [26]

353

90 (25)

MI, stroke, cardiovascular death, death from any cause

no recurrent stroke, no MI

4 cardiovascular deaths, 6 other deaths

pre-eclampsia

up to 16 years

Lanzino et al. (1991) [19]

59

2 (3)

Cerebral ischemia, MI, death

no recurrent strokes

nr

nr

mean 5.8 y, range 6 mo-11 y

  1. CVT cerebral venous thrombosis, MI myocardial infarction, PE pulmonary embolism, DVT deep venous thrombosis, SLE systemic lupus erythematosus, APS antiphospholipid syndrome, DM diabetes mellitus, y year, mo month, nr not reported for women with PAS